News and events
Jon Sawyer talks to MM&M about the new world of pharma marketing—and closerlook’s place in it.
Medical Marketing & Media ‒ November 2013
Long-time closerlook principal Jon Sawyer met with Medical Marketing & Media to discuss his new role as President and COO, and the company’s vision for the future.
“Dave [closerlook CEO David Ormesher] and I have spent a lot of time…strategically, thinking through the direction of the firm. This move formalizes the partnership between Dave and myself and strengthens our resolve to be a premier partner in HCP relationship marketing for pharma,” said Sawyer.
In his new role, he plans:
- To continue to push closerlook’s decade-long experience in relationship marketing in support of new ways in which marketing can enrich the critical relationship between physicians and pharma; and
- To establish closerlook as a key strategic resource for pharma companies wishing to take their relationship marketing efforts to the next level.
“Innovation in pharma marketing has been about new tactics and channels for too long. It’s time for the industry to embrace smarter marketing that aims to make more from what we already have, and focus on providing value beyond our products to physicians and patients. “If your relationship marketing program is limited to an e-mail campaign or two, then there’s a lot more to do,” Sawyer commented.
One of closerlook’s tenets has long been that relationship marketing in pharma is achievable, but that it’s a new way of thinking about marketing—that above all else, it requires a customer-centric mindset and behavior across the organization.
“Better is always an option. We have to move forward,” says Sawyer. “Pharma is in a great state of change, whether it be the Affordable Care Act or decreased access. We think there's a real opportunity in this new world we're entering. We’re ready for it and we're excited to take our place.”
The drugs, Optistavin, Easovartis and Librylin, and names, results, case studies and specific information, referenced in this advertisement are fictional and were created solely for illustrating the digital marketing capabilities of closerlook, inc. Any resemblance to actual drugs, medications, treatments, persons, living or dead, or to actual events, is purely coincidental. closerlook, inc. does not assume and hereby disclaims any liability to any party for any loss, damage or disruption caused by such party’s reliance on the fictitious information contained in this illustration.